While secondary outcomes should be interpreted cautiously in the face of overall non-significant results for the primary outcome, our findings suggest potential harm with L-C supplements, both for worsening cardiometabolic risk factors (i.e., LDL-C) and for atherosclerosis progression (i.e., stenosis)
In an animal model of acute inflammation, semaglutide decreased levels of plasma markers of systemic inflammation and down-regulated multiple inflammatory pathways vs controls, and was associated with significant attenuation of plaque lesion development [39]
Type 2 diabetes often involves insulin resistance, reduced insulin response, or both
Y., Meier, F
Heres an in-depth look at where and how to inject semaglutide safely and effectively
Published November 8, 2023